Prevail Therapeutics, Inc. (Prevail), a biotechnology company developing gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases, today announced the appointment of Francois Nader, M.D., to its Board of Directors.
May 24, 2018
· 2 min read